Business Context and Reporting Period
Company: MDxHealth SA
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: Month of May 2023
Filing Date: May 26, 2023
Principal Executive Office: Herstal, Belgium
This filing serves to furnish a press release issued by the Company on May 25, 2023, attached as Exhibit 99.1. The filing explicitly states that the information in the attached press release is not deemed "filed" under Section 18 of the Securities Exchange Act of 1934 and is not incorporated by reference into other filings unless expressly stated.
Key Financial Metrics
The provided filing text does not contain specific financial data. No values are reported for revenue, profit, cash flow, margins, debt, or liquidity within this document.
Material Changes
The filing text does not disclose specific material changes to financial performance or operations. The document solely references the issuance of a press release on May 25, 2023, without summarizing its content.
Guidance, Outlook, and Risks
The filing text does not provide management commentary, guidance, outlook, or specific risk factors. It notes that the attached press release is not subject to the liabilities of Section 18 of the Exchange Act.
Investor Verification Checklist
- Review the attached Exhibit 99.1 (Press Release dated May 25, 2023) for the actual substance of the announcement, as the Form 6-K text only references it.
- Verify if the press release contains material non-public information or updates to financial guidance.
- Confirm the legal status of the information, noting the disclaimer that the press release is not deemed "filed" for liability purposes under the Exchange Act.